Tanaka Growth Fund (TGFRX)

Fund Assets	37.26M
Expense Ratio	1.88%
Min. Investment	$2,000
Turnover	23.35%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	n/a
Ex-Dividend Date	Dec 18, 2025

Previous Close	60.04
YTD Return	5.90%
1-Year Return	-4.57%
5-Year Return	69.82%
52-Week Low	54.74
52-Week High	70.62
Beta (5Y)	1.22
Holdings	25
Inception Date	Dec 30, 1998

About TGFRX

The Tanaka Growth Fund Class R is a mutual fund focused on achieving capital growth through investments primarily in common stocks and equity securities across small, medium, and large capitalization companies. Managed by Tanaka Capital Management, the fund actively seeks out companies that its investment advisor believes have strong growth potential, both within the United States and internationally—allocating up to 45% of its assets to foreign and emerging market securities. As a non-diversified fund, Tanaka Growth Fund Class R often takes concentrated positions in a select group of holdings, leading to an overweight in certain key sectors, most notably technology, healthcare, and financial services. This investment approach allows the fund to capitalize on high-conviction opportunities. Due to its non-diversified structure and sector emphasis, the fund may experience periods of higher volatility compared to diversified funds. It carries a relatively high expense ratio, reflecting its active management style. The fund’s portfolio is characterized by a significant portion of assets allocated to top holdings, underscoring its targeted growth strategy and focused approach to capital appreciation.

• Fund Family: Tanaka
• Category: Multi-Cap Core
• Performance Rating: Average
• Risk Rating: High
• Stock Exchange: Nasdaq
• Ticker Symbol: TGFRX
• Share Class: Class R
• Index: Index is not available on Lipper Database

Performance

TGFRX had a total return of -4.57% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.38%.

Equivalent Funds

These are funds that follow the same index from the other major fund companies.

Symbol	Provider	Name	Expense Ratio
FZROX	Fidelity	Fidelity ZERO Total Market Index Fund	n/a

Top 10 Holdings

58.49% of assets

Name	Symbol	Weight
Corcept Therapeutics Incorporated	CORT	9.14%
NVIDIA Corporation	NVDA	7.41%
United States Antimony Corporation	UAMY	7.34%
Nuvation Bio Inc.	NUVB	5.83%
NexGen Energy Ltd.	NXE	5.54%
Aura Minerals Inc.	AUGO	5.49%
Apple Inc.	AAPL	5.15%
Intellia Therapeutics, Inc.	NTLA	4.39%
Applied Materials, Inc.	AMAT	4.38%
Electrovaya Inc.	ELVA	3.82%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 18, 2025	$7.39348	Dec 18, 2025
Dec 27, 2024	$3.15651	Dec 27, 2024
Dec 27, 2022	$0.03145	Dec 27, 2022

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error